Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MMP2 | P08253 | 2/20 | 0.47 |
| ▸ | MMP9 | P14780 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20189709 | 1.00 | KMT2A (0.51) | KMT2AMMP2MMP9CYP1A2RAB9A | |
| SCHEMBL27076462 | 0.87 | SLC1A3 (0.48) | MMP2MMP9SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7274405 | 0.84 | GGH (0.52) | KMT2AMMP9CYP1A2RAB9AMAPT | |
| SCHEMBL7274402 | 0.84 | GGH (0.52) | KMT2AMMP9CYP1A2RAB9AMAPT | |
| SCHEMBL27657427 | 0.84 | RAB9A (0.47) | KMT2ACYP1A2RAB9AMAPTNPC1 | |
| SCHEMBL3448329 | 0.84 | KMT2A (0.64) | KMT2AMMP2MMP9MAPTL3MBTL1 | |
| SCHEMBL3448327 | 0.84 | KMT2A (0.64) | KMT2AMMP2MMP9MAPTL3MBTL1 | |
| SCHEMBL2820711 | 0.83 | PPARG (0.54) | KMT2ACYP1A2RAB9AMAPTNPC1 | |
| SCHEMBL27469903 | 0.83 | PPARG (0.54) | KMT2ACYP1A2RAB9AMAPTNPC1 | |
| Hydrochloric Acid SCHEMBL23834278 | 0.82 | KMT2A (0.62) | KMT2AMMP2MMP9MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353814-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION (US) | 2025-11-20 | — | — | US | claimed |
| US-12404236-B2 | Non-peptidic cell-penetrating motifs | OHIO STATE INNOVATION FOUNDATION (US) | 2025-09-02 | — | — | US | claimed |
| US-12329799-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | OHIO STATE INNOVATION FOUNDATION (US) | 2025-06-17 | — | — | US | claimed |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION | 2024-03-28 | — | — | US | claimed |
| CN-117567639-A | Polypeptide conjugates for intracellular delivery of binding peptides | 俄亥俄州国家创新基金会 | 2024-02-20 | — | — | CN | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-11814341-B2 | Non-peptidic cell-penetrating motifs | OHIO STATE INNOVATION FOUNDATION (US) | 2023-11-14 | — | — | US | claimed |
| US-20230212235-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-06 | — | — | US | claimed |
| CN-115135665-A | Cyclic proteins comprising cell penetrating peptides | 俄亥俄州国家创新基金会 | 2022-09-30 | — | — | CN | claimed |
| WO-2021138397-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | OHIO STATE INNOVATION FOUNDATION (US) | 2021-07-08 | — | — | WO | claimed |
| US-20260125426-A1 | CYCLIC CELL-PENETRATING PEPTIDES AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260098262-A9 | COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY | ENTRADA THERAPEUTICS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260070947-A1 | CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS | OHIO STATE INNOVATION FOUNDATION (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260070948-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH CARGO | OHIO STATE INNOVATION FOUNDATION (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4706689-A2 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | Entrada Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-3544623-A1 | CELL-PENETRATING PEPTIDE SEQUENCES | Ohio State Innovation Foundation (US) | 2019-10-02 | — | — | EP | disclosed |
| WO-2019148194-A2 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019148195-A2 | CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | disclosed |
| WO-2019070962-A1 | BICYCLIC PEPTIDYL INHIBITORS | OHIO STATE INNOVATION FOUNDATION (US) | 2019-04-11 | — | — | WO | disclosed |
| WO-2018098231-A1 | CELL-PENETRATING PEPTIDE SEQUENCES | OHIO STATE INNOVATION FOUNDATION (US) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404236-B2 | Non-peptidic cell-penetrating motifs | TIMM50, TIMM10, PITRM1 | KMT2A 4862/4885MMP2 1219/4885MMP9 2041/4885 |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | KMT2A 4862/4885MMP2 1219/4885MMP9 2041/4885 |
| US-20250353814-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | KMT2A 4862/4885MMP2 1219/4885MMP9 2041/4885 |
| US-20230212235-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | LNPEP, SPPL2B, CNBP | KMT2A 4379/4885MMP2 629/4885MMP9 1192/4885 |
| US-20260098262-A9 | COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY | UTRN, SMN1; SMN2, UPF1 | KMT2A 2310/4885MMP2 3212/4885MMP9 2724/4885 |
| US-20260125426-A1 | CYCLIC CELL-PENETRATING PEPTIDES AND USES THEREOF | SLC7A1, TAP1, SLC7A5 | KMT2A 2819/4885MMP2 1466/4885MMP9 702/4885 |
| US-20260070947-A1 | CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS | SLC7A1, SLC38A7, SLC6A19 | KMT2A 4374/4885MMP2 339/4885MMP9 355/4885 |
| US-11814341-B2 | Non-peptidic cell-penetrating motifs | TIMM50, TIMM10, PITRM1 | KMT2A 4862/4885MMP2 1219/4885MMP9 2041/4885 |
| US-20260070948-A1 | CYCLIC CELL-PENETRATING PEPTIDES WITH CARGO | SLC7A1, SLC38A7, SLC6A19 | KMT2A 3978/4885MMP2 550/4885MMP9 734/4885 |
| US-12329799-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | CHP1, NFATC1, PPP3R1 | KMT2A 3612/4885MMP2 3863/4885MMP9 4113/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | KMT2A 3612/4885MMP2 3863/4885MMP9 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.